For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
As of close of business last night, NovoCure Ltd’s stock clocked out at $20.62, down -3.28% from its previous closing price of $21.32. In other words, the price has decreased by -$3.28 from its previous closing price. On the day, 1.3 million shares were traded. NVCR stock price reached its highest trading level at $21.5499 during the session, while it also had its lowest trading level at $20.35.
Ratios:
To gain a deeper understanding of NVCR’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.42 and its Current Ratio is at 1.46. In the meantime, Its Debt-to-Equity ratio is 1.90 whereas as Long-Term Debt/Eq ratio is at 0.33.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Evercore ISI on December 02, 2024, Upgraded its rating to Outperform and sets its target price to $30 from $18 previously.
On October 16, 2024, H.C. Wainwright Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $24 to $30.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 03 ’25 when Weinberg Uri sold 268 shares for $18.92 per share. The transaction valued at 5,071 led to the insider holds 166,243 shares of the business.
Leonard Frank X sold 2,527 shares of NVCR for $46,841 on Mar 03 ’25. The EVP, Pres., Novocure Oncology now owns 143,673 shares after completing the transaction at $18.54 per share. On Mar 03 ’25, another insider, Cordova Ashley, who serves as the Chief Executive Officer of the company, sold 2,053 shares for $18.54 each. As a result, the insider received 38,055 and left with 204,005 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NVCR now has a Market Capitalization of 2266447360 and an Enterprise Value of 2066864000. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.74 while its Price-to-Book (P/B) ratio in mrq is 6.21. Its current Enterprise Value per Revenue stands at 3.415 whereas that against EBITDA is -13.109.
Stock Price History:
The Beta on a monthly basis for NVCR is 0.55, which has changed by 0.41136205 over the last 52 weeks, in comparison to a change of 0.087141395 over the same period for the S&P500. Over the past 52 weeks, NVCR has reached a high of $34.13, while it has fallen to a 52-week low of $11.70. The 50-Day Moving Average of the stock is -14.39%, while the 200-Day Moving Average is calculated to be -0.63%.
Shares Statistics:
It appears that NVCR traded 998.29K shares on average per day over the past three months and 1448850 shares per day over the past ten days. A total of 108.52M shares are outstanding, with a floating share count of 98.34M. Insiders hold about 10.53% of the company’s shares, while institutions hold 83.64% stake in the company. Shares short for NVCR as of 1740700800 were 5216483 with a Short Ratio of 5.23, compared to 1738281600 on 4971800. Therefore, it implies a Short% of Shares Outstanding of 5216483 and a Short% of Float of 5.6500003.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
